PT Bio Farma: COVID-19 trials

The registry lists 12 COVID-19 studies with PT Bio Farma as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 5Phase 3 3No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Post Authorization Safety Profile of Booster IndoVac COVID-19 VaccinationCompletedNCT06690502
• Post Authorization Safety Study Moderna COVID-19 Primary VaccineCompletedNCT06006858
• Homologous Booster Study of COVID-19 Protein Subunit Recombinant VaccineCompletedNCT05933278Phase 2
• Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of AgeCompletedNCT05727215Phase 2
• Booster Study of COVID-19 Protein Subunit Recombinant VaccineCompletedNCT05525208Phase 2
• Immuno-bridging Study of COVID-19 Protein Subunit Recombinant VaccineCompletedNCT05433285Phase 3
• Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant VaccineCompletedNCT05313035Phase 2/3
• Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018CompletedNCT05228613Phase 1
• Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)Status unknownNCT05172193Phase 2
• The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated VaccineStatus unknownNCT05126550
• Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant VaccineCompletedNCT05067894Phase 1
• Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated VaccineCompletedNCT04508075Phase 3